6th Russian-Swedish Economic Forum 2016 "New investment potential: ideas and opportunities"

24 November 2016, Lidingö, Sweden.
Russia has set a course for supporting the latest scientific research and, in particular, on drugs, and transferring the new technologies to Western markets. One example of such developments is the project by the Biomedical Centre of St. Petersburg, led by Professor Andrey Kozlov. This private think tank researches the role of epidemiological approaches to the fight against HIV and AIDS, develops new concepts of active preventative measures and has been working on a vaccine against the virus since 1994. Some of the potential vaccines developed at the Centre have successfully passed their pre-clinical and clinical trials and are now awaiting state support for conducting the 2nd and 3rd phases of the clinical trials.

The Science Magazine has praised the Biomedical Centre of St. Petersburg as an 'island of talented investigators' for their contribution to 'clarifying the rate of spread of HIV among injecting drug users and documenting the transmission from IDUs into the broader population through heterosexual sex'. The magazine said that Russian scientists arrived at the very epicentre of research on vaccines against HIV and that the importance of their work goes far beyond the Russian borders.

The initiative put forward by the Industry and Trade Ministry in 2016 was aimed at helping such promising innovative developments to enter the market. This initiative has seen the launch of a programme for promoting, expert trials, analytical support and business acceleration for research projects which have earlier received state funding.

The programme was designed to support the development of successful research, reassess the projects' viability and patentability, and to analyse their technological and economic potential for scaling both in Russia and abroad.

The selection process involved assessment by a number of experts from a variety of fields, such as medicine, pharmaceuticals, innovations and intellectual property, as well as representatives of the business. Projects were reviewed by representatives of both the scientific and the methodological schools. Such an approach ensured a comprehensive assessment and eliminated any risk of a conflict of interests; one of the prerequisites for being an expert was having no connection to any of the participants of this project.

Such efforts to ensure independent assessment have been made as the Ministry aims to commercialise new technologies based on original ideas and latest developments on global markets as soon as possible. Russian drugs get approved by foreign investors who recognise their competitiveness with increasing frequency. Similarly, the global financial crisis and the rouble's devaluation against other currencies over the past few years have made the environment for joint projects in Russia more attractive and have worked in favour of such international syndicates.

The programme of the 6th Russian-Swedish economic forum on new investment potential, which will take place in Stockholm, includes a presentation of the project office and Russian innovative projects in pharmaceuticals and biotechnologies on 24 November.

In 2017 the Ministry of Industry and Trade of the Russian Federation is planning to expand the work of the independent project reviewing commission.

For further information about the 6th Russian-Swedish economic forum, please visit:
http://rysslandshandel.se/en/vi-russian-swedish-economic-forum-2016/

You can register for the 6th Russian-Swedish economic forum here: http://rysslandshandel.se/forum/forum2016_registration.php

Most Popular Now

Regorafenib to be tested in brain cancer patients …

Bayer announced that the regorafenib arm of the platform trial "GBM AGILE" (Glioblastoma Adaptive Global Innovative Learning Environment) opened for enrollment in the US ...

Sanofi and Google to develop new healthcare Innova…

Sanofi and Google will establish a new virtual Innovation Lab with the ambition to radically transform how future medicines and health services are delivered by tapping i...

Bristol-Myers Squibb provides update on pending me…

Bristol-Myers Squibb Company (NYSE: BMY) today provided an update on the approval process and timeline for the Company’s pending merger with Celgene Corporation (NASDAQ: ...

Japan becomes the first country to approve Roche's…

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Rozlytrek® (entrectinib) for the treatment of a...

Breztri Aerosphere (PT010) approved in Japan for p…

AstraZeneca announced that Breztri Aerosphere (budesonide/glycopyrronium/ formoterol fumarate), formerly PT010, has been approved in Japan as a triple-combination therapy...

FDA approves Amgen and Allergan's KANJINTITM (tras…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that the U.S. Food and Drug Administration (FDA) has approved KANJINTITM (trastuzumab-anns) for all approved ind...

Vitamin D may not help your heart

While previous research has suggested a link between low levels of vitamin D in the blood and an increased risk of cardiovascular disease, a new Michigan State University...

Human-on-a-chip model tests cancer drug efficacy a…

A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organ...

Pathogen engineered to self-destruct underlies can…

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-dest...

Artificial DNA can control release of active ingre…

A drug with three active ingredients that are released in sequence at specific times: Thanks to the work of a team at the Technical University of Munich (TUM), what was o...

How gastric stem cells fight bacteria

Stem cells are not only key players in tissue regeneration, they are also capable of taking direct action against bacteria. This is the finding of a study conducted by re...

Researchers identify enzyme that suppresses immune…

Immunotherapies have transformed cancer care, but their successes have been limited for reasons that are both complex and perplexing. In breast cancer especially, only a ...